RecruitingNCT03621839

New CSF Biomarkers for Alzheimer's Disease

New Diagnosis or Prognosis Biomarkers for Alzheimer's Disease: Biobank of CSF Collected as Part of Differential Diagnosis of Dementia


Sponsor

Central Hospital, Nancy, France

Enrollment

50,000 participants

Start Date

Jul 12, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

Today, the Alzheimer's disease (AD) diagnosis is founded not only on clinical criteria but also on complementary examinations to confirm a physiopathological process of AD. In complex cases, lumbar punction could be necessary in order to measure Aβ peptides and Total and phosphorylated Tau but new biomarkers could be useful. The main objective of this project is to conserve these cerebrospinal fluids, collected in usual practice in order to validate new biomarkers for diagnosis, prognosis or therapeutic following of Alzheimer's disease and other dementia.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is collecting samples of cerebrospinal fluid (the fluid around the brain and spinal cord) from people undergoing a lumbar puncture (spinal tap) as part of their routine memory loss or dementia evaluation, to search for new biological markers that could help diagnose Alzheimer's disease earlier and more accurately. **You may be eligible if...** - You are already undergoing a lumbar puncture (spinal tap) as part of your routine care for a dementia or memory disorder evaluation - You are willing to give consent to have your samples included in the study **You may NOT be eligible if...** - You do not give consent for your samples to be used in the study - Your lumbar puncture is being done for a reason unrelated to memory or dementia assessment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHRU De Nancy

Nancy, Grand Est, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03621839


Related Trials